Last reviewed · How we verify
NCT03862599: LiST-PRP
Low Intensity Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy
NA trial testing Extra-corporeal shockwave therapy (ESWT) in Erectile Dysfunction Following Radical Prostatectomy in 100 participants. Status unknown.
1 October 2024
Quick facts
| Lead sponsor | Guy's and St Thomas' NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 June 2021 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 May 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Extra-corporeal shockwave therapy (ESWT)
- Standard care — full drug profile →
Conditions studied
- Erectile Dysfunction Following Radical Prostatectomy — all drugs for Erectile Dysfunction Following Radical Prostatectomy →
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Who can join
Adults 40 to 65, male only, with Erectile Dysfunction Following Radical Prostatectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical prostatectomy for prostate cancer. A few small studies have recently shown that low-intensity shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage and length of treatment is yet to be determined. The investigators propose a randomised trial evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED following prostatectomy surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Use of the Shock Wave Therapy in Basic Research and Clinical Applications-From Bench to Bedsite.
Rola P, Włodarczak A, Barycki M, Doroszko A. · · 2022 · cited 18× · PMID 35327369 · DOI 10.3390/biomedicines10030568
Verify or expand the search:
- PubMed search for NCT03862599
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Erectile Dysfunction Following Radical Prostatectomy
Currently open trials in the same condition.
- NCT07520916 — The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatec · NA · recruiting
- NCT06605508 — Regenerative Injection of Stem Cells or Stem Cell-derived Exosomes for Erectile Dysfunction (RISE) · recruiting
- NCT07101731 — Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy · NA · recruiting
- NCT06875258 — PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II) · Phase 4 · recruiting
- NCT05558007 — Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients · Phase 2 · recruiting
Other Guy's and St Thomas' NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07534917 — Comparing the Effects of Newer Pacemakers and Their Effects on the Heart and Valve Function in the Short-term. · not yet recruiting
- NCT07454135 — Mechanisms of Atrial Pathoelectrophysiology in HCM · not yet recruiting
- NCT07419945 — Older Kidney Patient Optimisation Pretransplant · NA · not yet recruiting
- NCT07309835 — Improving Genetic Medicine for Ethnic Minority Groups · not yet recruiting
- NCT07203872 — Inflammation-resolution Therapy in MINST of Periodontal Intrabony Defect: a Pilot Randomised Controlled Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03862599 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guy's and St Thomas' NHS Foundation Trust
- Last refreshed: 7 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03862599.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing